Frontlight ResearchEarly access
Trial site
Direction Centrale Du Service De Sante Des Armees
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Systemic sclerosis (scleroderma)2 trials
- Atopic dermatitis (eczema)1 trial
- Hidradenitis suppurativa1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Status
- Recruiting5 trials
- Completed4 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC4 trials
- Amgen1 trial
- Assistance Publique Hopitaux De Paris1 trial
- AstraZeneca1 trial
- Bayer1 trial
- and 5 more
Running trials
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
Recruiting
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Active, not recruiting
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
Closed trials
Completed
Completed
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026